Xenon Pharmaceuticals Inc.
XENE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $105 | $135 | $117 | $143 |
| Short-Term Investments | $358 | $352 | $433 | $484 |
| Receivables | $1 | $1 | $9 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $17 | $12 | $7 | $7 |
| Total Curr. Assets | $480 | $500 | $566 | $635 |
| Property Plant & Equip (Net) | $16 | $16 | $17 | $18 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $93 | $137 | $141 | $127 |
| Tax Assets | $12 | $11 | $11 | $10 |
| Other NC Assets | $7 | $9 | $8 | $7 |
| Total NC Assets | $128 | $174 | $178 | $163 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $608 | $674 | $743 | $798 |
| Liabilities | – | – | – | – |
| Payables | $5 | $5 | $7 | $5 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $2 | $7 | $6 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $32 | $25 | $17 | $23 |
| Total Curr. Liab. | $38 | $33 | $32 | $36 |
| LT Debt | $7 | $7 | $7 | $8 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $0 | $0 | $0 |
| Total NC Liab. | $10 | $7 | $7 | $8 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $9 | $9 | $9 |
| Total Liabilities | $48 | $40 | $39 | $43 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,475 | $1,469 | $1,461 | $1,457 |
| Retained Earnings | -$1,140 | -$1,049 | -$965 | -$899 |
| AOCI | $0 | $0 | -$1 | -$2 |
| Other Equity | $224 | $214 | $208 | $199 |
| Total Equity | $560 | $634 | $704 | $755 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $608 | $674 | $743 | $798 |
| Net Debt | -$96 | -$127 | -$108 | -$134 |